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Résumé en
anglais
Glioblastoma, the most frequent and lethal form of glioma, displays chromosome
instability and recurrent somatic copy number alterations (SCNA). Chromothripsis and
whole genome duplication (WGD) have been recently identified in cancer. In the
present study, we analyzed SCNA and determine the ploidy pattern in 123 -wild-type
glioblastomas, using SNP array data. WGD and chromothripsis events were validated
using, respectively, FISH and CTLPScanner. WGD was detected in 11.4%
glioblastomas (14/123) and was associated with mutation ( = 0.0068). It was an early
event occurring after the recurrent SCNA observed in diffuse high-grade gliomas.
Glioblastomas with WGD were more aneuploid compared to glioblastomas without
WGD ( < 0.0001). Chromothripsis occurred in 29.3% glioblastomas (36/123) and mostly
affected chromosomes 7, 9 and 12, with amplification of oncogenes (EGFR, /), and
homozygous deletion of tumor suppressor genes (). There was a significant association
between chromothripsis and gene rearrangement at a given locus. WGD is an early
genetic event significantly associated to mutation and leading to chromosome
instability and aneuploidy in -wild-type glioblastoma. Chromothripsis recurrently
targets oncogenes and tumor suppressor genes that are key players in gliomagenesis
and tumor progression. The occurrence of chromothripsis points to underlying gene
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